Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. The company develops a proprietary gene editing platform based on CRISPR technology...
Leadership
Gilmore O'Neill M.D.
President, CEO & Director
Amy Parison
Senior VP & CFO
Linda C. Burkly Ph.D.
Executive VP & Chief Scientific Officer
Feng Zhang Ph.D.Founder
Co-Founder & Scientific Advisory Board Member
George McDonald Church Ph.D.Founder
Co-Founder & Scientific Advisory Board Member
Gregory Whitehead
Executive VP and Chief Technical & Quality Officer
Damien Grierson J.D.
Senior VP, General Counsel & Corporate Secretary
Tom Love
Vice President of People
Frank Panaccio
Senior VP & Chief Business Officer
Brieana Buckley
Senior Vice President of Development and Program Leadership
